Search results for “Nonalcoholic fatty liver disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,706 patents, we discovered top 446 key players by total patent application. Schering Corp., Amgen, Inc., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 5.76% of the total patent filing.
New Jersey, United States
Patent: 56
California, United States
Patent: 50
Massachusetts, United States
Patent: 50
Indiana, United States
Patent: 47
Basel-Stadt, Switzerland
Patent: 44
Tianjin Shi, China
Patent: 41
Shanghai Shi, China
Patent: 40
California, United States
Patent: 38
Massachusetts, United States
Patent: 37
South Korea
Patent: 35
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 126 patents, we discovered top 22 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Brightseed, Inc., I2o Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 30
STARTUP
California, United States
Patent: 13
STARTUP
Massachusetts, United States
Patent: 12
STARTUP
South Korea
Patent: 10
STARTUP
South Korea
Patent: 10
STARTUP
New York, United States
Patent: 8
California, United States
Patent: 6
STARTUP
Massachusetts, United States
Patent: 6
STARTUP
DUBLIN, Ireland
Patent: 5
STARTUP
Massachusetts, United States
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,837 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Amgen, Inc., Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Enanta Pharmaceuticals, Inc. take 6.91% of patent filing during this period.
California, United States
Patent: 50
Shanghai Shi, China
Patent: 40
Massachusetts, United States
Patent: 37
Massachusetts, United States
Patent: 37
California, United States
Patent: 26
Switzerland
Patent: 21
France
Patent: 21
Indiana, United States
Patent: 20
Gyeonggi-do, South Korea
Patent: 19
STARTUP
France
Patent: 19
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,837 patents in last 5 years, we discover 338 new entrants. Amgen, Inc., Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Enanta Pharmaceuticals, Inc. are the most active new entrants in this area.
California, United States
Patent: 50
Shanghai Shi, China
Patent: 40
Massachusetts, United States
Patent: 37
California, United States
Patent: 26
Gyeonggi-do, South Korea
Patent: 19
Virginia, United States
Patent: 17
California, United States
Patent: 16
Zhejiang Sheng, China
Patent: 16
California, United States
Patent: 15
STARTUP
California, United States
Patent: 13
Research Institutions
Order by:
Innovation Intensity
With the analysis among 956 patents, we discovered top 201 universities and scientific research institutions by total patent application. China Pharmaceutical University, University of Strasbourg, Zhejiang University are dominant in this area. They take 13.81% of the total patent filing.
Jiangsu Sheng, China
Patent: 37
France
Patent: 19
Zhejiang Sheng, China
Patent: 15
Jiangsu Sheng, China
Patent: 15
Connecticut, United States
Patent: 13
Louisiana, United States
Patent: 13
Kanagawa-ken, Japan
Patent: 13
North Carolina, United States
Patent: 10
Jiangsu Sheng, China
Patent: 10
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: